PRESS RELEASE In the context of the obligations stipulated by the Rule 5/204/14.11.2000 of the Hellenic Capital Market Commission Board of Directors regarding an article in the financial press dated 03/12/2007, Gr.
ANNOUNCEMENT The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.
PRESS RELEASE Within the context of Sarantis Group’s strategic development, and with the aim to significantly reinforce the dynamics of the Group’s Health & Care division, the Group is including the French Company OENOBIOL in its product portfolio.
ANNOUNCEMENT The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.
ANNOUNCEMENT The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.
PRESS RELEASE Main Points Sarantis Group’s turnover increased by 13.16% to €173.96 mil. from €153.73 mil. in 9m 2006. Gross profit margin increased to 50.
ANNOUNCEMENT The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.
ANNOUNCEMENT The company GR. SARANTIS S.A. announces, according to the article 21 of the L.3556/2007 and the article 11 of the Hellenic Capital Market Commission decision 1/434/3.